
SPRAVATO® is the only FDA-approved nasal spray for adults with treatment-resistant depression, used alone or alongside an oral antidepressant.
It may help relieve symptoms of depression when other antidepressants have not been effective
It is an NMDA (N-methyl-D-aspartate) receptor antagonist that may work differently from traditional antidepressants by targeting glutamate.
Glutamate is a chemical messenger in the brain believed to play a role in mood regulation, though its exact role in depression remains unclear.
Learn how SPRAVATO® works and how treatment is provided.
Treatment-resistant depression occurs when symptoms do not improve after trying at least two different antidepressant medications at the right dose and duration.
Research shows that about 30% of people with depression meet the criteria for TRD.
At Innovative Women’s Healthcare, an FDA REMS-Certified Treatment Center, patients receive SPRAVATO® in a safe, comfortable, and closely monitored environment. Each session is conducted in-office under the supervision of a trained healthcare provider and followed by an observation period to ensure safety and comfort.
Our team is fully trained and certified to administer Spravato safely and effectively.
We manage all insurance documentation and approval processes on your behalf.
Enjoy private treatment rooms with continuous monitoring for your safety and comfort.
Our specialists have extensive expertise in treatment-resistant depression and ketamine-based therapies.
We’ve made it easy to access official SPRAVATO® materials to help you learn more about treatment: